WHP completes ADC Bio’s £5m cleanroom in UK site
WHP completes the building of a cleanroom facility at a site expected to deliver ‘the next generation of anticancer blockbuster ADC drugs’.
WHP completes the building of a cleanroom facility at a site expected to deliver ‘the next generation of anticancer blockbuster ADC drugs’.
Catalent Biologics works with Novartis to develop and manufacture its SMA gene therapy treatment and provide manufacturing capacity, as the treatment enters the market.
J&J will test a vaccine candidate for HIV prevention in 3,800 men across the US and Europe, at the same time as ViiV releases positive comparative data on its HIV treatment.